Introducing an Anti-Terminator Paralog Gene to Induce Production of Natural Products in Clostridium Species by Leung, Alexander
UC Berkeley
Berkeley Scientific Journal
Title
Introducing an Anti-Terminator Paralog Gene to Induce Production of Natural Products in 
Clostridium Species
Permalink
https://escholarship.org/uc/item/2vp44226
Journal
Berkeley Scientific Journal, 23(2)
ISSN
1097-0967
Author
Leung, Alexander
Publication Date
2019
 
Peer reviewed|Undergraduate
eScholarship.org Powered by the California Digital Library
University of California
68               Berkeley Scientific Journal | SPRING 2019
INTRODUCTION
Bacteria have been studied for their ability to form natural products 
that can be useful for drug discovery and other applications, such as dyes 
and other synthetic materials. Some natural products come in the form 
of secondary metabolites, which have been observed from Clostridium.1 
The genomes of different Clostridium species have been studied for sec-
ondary metabolite sequences, such as polyketide synthase and non-ri-
bosomal peptide synthetase genes, which are widespread amongst these 
species.1 These genes are only activated by particular stimuli, such as 
environmental conditions found in aqueous soil extract.1 Since the nec-
essary stimulatory environmental conditions are difficult to recreate in a 
laboratory setting, bacteria are often incapable of producing secondary 
metabolites in vitro due to the dormancy of usual secondary metabolite 
biosynthetic pathways.  In a previous study, overexpression of anti-ter-
minator genes corresponding to biosynthetic gene clusters in Clostrid-
ium celluloyticum yielded novel natural products such as antibiotics 
known as closthioamides and related thioamides.1
In the former study, an anti-terminator gene was used to induce 
a secondary metabolite pathway. This class of proteins is referred to as 
LoaP. LoaP is a paralog from the nusG family of proteins, which tend 
to play an important role in transcription elongation.2 Anti-termina-
tor proteins prevent termination of transcription at terminator sites, 
and allow for expression in the sequences beyond them.3  In the ab-
sence of an anti-terminator protein, RNA polymerase, or RNAP, will 
cease transcription at a terminator. In this context, the anti-terminator 
serves to increase the overall rate of transcription.1 In RNAP complex-
es, nusG moves transcription forward past termination sites (known as 
p-dependent sites), which increases RNA polymerase processivity and 
helps with both making transcription efficient1 and driving the creation 
of polycistronic mRNA.1 Overall, this process helps the progression of 
protein production. We hypothesized that this may drive a different 
pattern of gene expression, which may in turn drive some biosynthetic 
gene pathways.
Overexpression of these anti-terminator genes in biosynthetic clus-
ters may give rise to novel natural products produced by Clostridium 
beijerinckii, which is also known as B-598.  In B-598, a paralog of nusG 
called LoaP was discovered.2 If the B-598 paralog were to be excised 
from B-598’s bacterial genome and placed as an insert into B-598’s 
genome under a different constitutive promoter, it should activate a 
biosynthetic gene cluster and, potentially, create cryptic natural prod-
ucts. In our study, the LoaP protein was expressed under a constitu-
tive promoter called Pbdh, which is from a different bacterial species 
known as Clostridium saccharoperbutylacetonicum.2 Pbdh typically reg-
ulates butanol dehydrogenase. Promoters are sequences of DNA where 
transcription is initiated. Promoters are also important in regulating 
expression of downstream genes. There is a possibility that anti-termi-
nator proteins will not be expressed in certain promoters. The promot-
er Pbdh was selected due to its constitutive nature, which ensures that 
it is continuously active and, therefore, does not need to be induced. 
Once the anti-terminator proteins are expressed under this promoter, 
a cryptic biosynthetic pathway can be driven in B-598 to yield novel 
natural products such as secondary metabolites. Figure 1 shows that the 
sequence used was associated with Cluster 10, which is a biosynthetic 
cluster that was hypothesized to be responsible for secondary metabo-
lite activity. From this, it is possible that overexpression of LoaP in B-598 
using a constitutive promoter may yield novel natural products.
MATERIALS AND METHODS
I. Cloning and Gibson Assembly
Cloning was done by inserting the B-598 nusG into the backbone 
of B-598 under the Pbdh promoter. Lab restriction enzymes are used 
to cut out B-598’s native nusG and replace it with B-598’s LoaP under a 
different promoter. The backbone in this procedure is named PJL5. Its 
native nusG is cut out with BSP/MSSI, and generates sticky ends to fa-
cilitate insertion of the B-598’s LoaP.  B-598’s paralog was also amplified 
via PCR to generate the plasmid DNA sequence of B-598. Both the PCR 
product and restriction digests were run in a gel electrophoresis proce-
dure that separates out the bands so that they may be cut out of the gel 
and purified in a gel extraction procedure. These same restriction en-
zymes were also used to cut out LoaP from B-598’s plasmid sequence to 
make it homologous to the cut-out site in PJL5. B-598’s LoaP sequence 
was then ligated to the PJL5 plasmid, and the new plasmid was named 
PJL9.
However, it was discovered that restriction digest enzymes were not 
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Figure 2. nusG B-598 insert 
(LoaP) placed into the back-
bone DNA sequence of B-598 
to yield the PJL9 sequence.
needed as the Gibson Assembly procedure helped to create sticky ends 
to avoid blunt-end DNA ligation. The Gibson Assembly procedure has 
the same principle as the restriction enzyme procedure and it was used 
in this experiment to generate the constructs. Without Gibson Assem-
bly, in blunt-end DNA ligation, the LoaP insert may not have necessar-
ily ligated to the correct site and may have ligated to any other available 
homologous site. Luckily, PJL9 was successfully constructed using Gib-
son Assembly. The theoretical construct created was seen in a model 
of the plasmid shown in Fig. 2. The sequence was also confirmed to be 
correct through a sequencing facility.
After PJL9 was generated, it was inserted into a bacterial colony via 
a transformation procedure. 5 μL of the plasmid’s DNA was added to 
one 50 μL aliquot of E. coli XL-1 Blue competent cells.  The mixture was 
then incubated on ice for 30 minutes, before undergoing heat shock. 
In heat shock, the mixture was placed in a 42°C bath for 45 seconds. 
During the heat-shock step of the transformation procedure, E. coli 
XL-1 Blue competent cells incorporated the plasmid. The constructed 
plasmid was amplified as the colony was grown on an LB plate with 
a Carbenicillin antibiotic. Colonies on the media surface were picked 
and grown in liquid LB media in sterile tubes until the media showed 
cloudiness or bacterial growth. The DNA was extracted from the XL-1 
Blue competent cells via a Zyppy Plasmid mini-prep procedure to ob-
tain the sequence of the constructed plasmids. In order to confirm that 
the sequence is correct, test digests were run on the extracted DNA with 
a HindIII restriction enzyme. Constructs with the correct bands were 
prepared for sequencing and submitted to a sequencing facility to con-
firm if the insert had successfully ligated to the backbone. 
II. Transformation into B-598
After extracting the DNA from E. coli cells, running test digests, 
and confirming the sequences are correct through the sequencing facili-
ty, the final PJL9 plasmid was incorporated into B-598 colonies.  The lab 
had developed a specialized transformation procedure specifically that 
was implemented for this experiment.4
III. Fermentation and Chemical Extraction
The transformants were grown in TYA media with antibiotic 
erythromycin at 40 μg/mL for four days.5 In addition, a wild-type bac-
terial control was grown alongside the transformants (also known as 
LoaP overexpression strains) in order to serve as a basis for comparison. 
Both colonies were grown in triplicate cultures, meaning there were 
three samples for the transformants and three samples for the wild-type 
bacteria in order to ensure that there are enough data to compare and 
demonstrate consistency.  After 4 days, the transformants and wild-type 
bacteria were chemically extracted with EtOAc. EtOAc was added to 
the liquid cultures in a 1:1 ratio, before being vortexed. Afterwards, the 
mixture was spun down, the top layer was removed, then dried with ni-
trogen lines. The resulting extract was then suspended in HPLC-grade 
methanol and run in a quadrupole time-of-flight (QTOF) mass spec-
trometer for analysis.
Figure 1. B-598 
derived LoaP 
Associated with 
Cluster 10 and 
Used in the
Experiment.8
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IV. QTOF/XCMS
Compounds were separated out through MS-Reverse-Phase 
HPLC. The mass-to-charge ratio of both the transformants and wild-
type colonies were analyzed to see what compounds are being produced. 
However, in order to narrow down whether the transformants have a 
new compound or are missing compounds, an XCMS procedure was 
implemented. XCMS is a data-analysis approach for mass spectrometry 
data that examines spectrometry variables such as peak matching, peak 
detection, retention time alignment, etc.7 In this study, XCMS generated 
a table with 1 row for every single mass peak detected. It then calculat-
ed the average size of that peak for each replicate and took the average 
of these values. The most significant variables in this study are median 
retention times, fold changes, and p-values. Median retention times sig-
nify how long the peak was observed in the sample. Since the machine 
has a 55-minute gradient, only a range of 2 to 57 minutes was consid-
ered.7 Fold change reflects the difference between the average LoaP and 
control value and a 10-fold change is usually significant.7 P-value indi-
cates how statistically significant are the results, 0.01 or 0.05 being the 
cutoff.  Using these three variables, the rows were narrowed down to 
obtain only significant results.  Each row corresponds to a new peak, 
which then means that either a new mass was found or a typical mass 
is missing. After the rows were obtained, we returned to the raw data to 
analyze significant results.
RESULTS
The mass-to-charge ratio that was significant as identified from the 
XCMS method was 730.5358 m/z. This value satisfies the XCMS proce-
dure by having a p-value larger than our cutoff of 0.01 and 0.05, while 
also having nearly a 10-fold change as indicated by Table 1. The chro-
matogram indicated a possible major significant difference between the 
LoaP overexpression and control samples as seen in Fig. 3.  There are six 
curves in total to signify three wild-type samples and three LoaP sam-
ples. The LoaP curves were close to the baseline, indicating that the mass 
was not present in all three LoaP overexpression samples.  Meanwhile, 
all wild-type curves showed high counts, indicating that the mass was 
present in a pretty high quantity as opposed to the LoaP overexpression 
samples. Another QTOF data file comparing counts to mass-to-charge 
ratio in Fig. 4 serves to confirm that the mass is present in the wild-type. 
Overall, the results indicate that a nonpolar compound was produced in 
the wild-type bacteria, but not the B-598 derived LoaP overexpression 
samples. This serves to show that the mutant strain was eliminating a 
product that would usually be created in the wild-type colonies.
DISCUSSION
The results obtained were unexpected, and contradicted the orig-
inal hypothesis. Based on previous studies2 we expected that inserting 
anti-terminator genes into bacterial genomes could change gene ex-
pression and activate biosynthetic pathways that can create new sec-
ondary metabolites.  However, the results indicated that an unknown 
compound that was produced in the wild-type was not produced by the 
B-598 derived LoaP samples.  In fact, it seemed as if the anti-terminator 
protein may have decreased production of one of the compounds usual-
ly produced. However, re-analysis of the B-598 genome indicated there 
are actually two LoaP sequences within the genome. The sequence used 
in the experiment was hypothesized to be associated with secondary 
metabolite biosynthetic gene clusters. Perhaps the loss of one product 
could be due to the fact that the sequence had some minor secondary 
effects that inhibited the creation of that one product. What exactly are 
the secondary effects is unknown at this time, although it can be theo-
rized that LoaP served as a negative regulator for that product. Namely, 
Figure 3. Chromatogram comparing 
B-598 LoaP overexpression strains versus 
wild-type. Orange, black, and pink curves 
represent the wild-type bacteria, while 
red, blue, and green curves represented 
the transformants with the LoaP. The 
graph indicates that the 730.5358 m/z 
mass eluted from the column at fifty-five 
minutes.
Figure 4. Counts versus mass charge 
confirming the presence of the 730.5358 
m/z in the wild-type bacteria.
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Table 1. Statistical variables 
from XCMS Procedure Corre-
sponding to the 730.5358 m/z.
it would prevent a certain gene from being expressed, thereby inhib-
iting the pathway that would otherwise create the product. In the fu-
ture, the copy of LoaP found (associated with Cluster 18, Fig. 6), will be 
used instead to see if that induces the B-598 strain to create new natural 
products. Analysis of the cluster indicates that Cluster 18 might be a 
biosynthetic pathway for saccharides, which are primary metabolites. 
Regardless, overexpressing this copy might yield more fruitful results 
than the B-598 sequence in Cluster 10.  In future work, the cloning pro-
cedure could be repeated for this homolog and inserted into B-598 to be 
overexpressed under the same promoter to test its ability to induce sec-
ondary metabolites. We hypothesize that a LoaP copy that is associated 
with a saccharide cluster could induce cryptic biosynthetic pathways 
of new metabolites when inserted into B-598. Another alternative is to 
search for other proteins often associated with heavy biosynthetic gene 
clusters (preferably anti-terminators) and undergo the same procedure 
to study secondary metabolite effects. Preferably, these proteins need to 
be positive regulators so that they simply can be expressed under the 
same promoters using the same cloning procedure mentioned above.
CONCLUSION
Theoretically, overexpression of the nusG vector in bacteria would 
help to induce bacteria into creating natural products such as antibi-
otics. However, the LoaP overexpression strain demonstrated the op-
posite of what was expected. In the chromatogram results, the wild-
type bacteria were discovered to contain a peak with a mass that the 
transformant strain lacked. This runs contrary to the hypothesis that 
the insertion of the B-598 derived LoaP into B-598 would induce bio-
synthetic pathways in B-598, which could in turn create useful prod-
ucts like closthioamide.2 The sequence inserted into B-598’s decreased 
production in the bacteria. This could be due to the fact that the se-
quence used had some secondary effects that inhibited creation of the 
expected product. In the future, another LoaP sequence associated 
with a saccharide gene cluster can be inserted into the B-598 genome 
and studied for secondary metabolite activity.  Other proteins similar 
to LoaP can also be used in a similar fashion to induce secondary me-
tabolite activity. 
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LoaP copy associated 
with Cluster 18, a saccha-
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